Metabolism Informed Smoking Treatment: The MIST RCT
Status:
Recruiting
Trial end date:
2026-11-01
Target enrollment:
Participant gender:
Summary
This phase 3 randomized controlled trial will test Metabolism-Informed Smoking Treatment
(MIST), a precision approach to smoking treatment that biologically tailors medication
selection to nicotine metabolism.
Phase:
Phase 3
Details
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH)